These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4953937)

  • 1. [Influence of phenylbutazone and ketophenylbutazone on the gastrointestinal tract].
    Horakova Z; Metys J; Cepelak V
    Therapie; 1965; 20(3):617-30. PubMed ID: 4953937
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of phenylbutazone and ketophenylbutazone on gastric secretion in animals].
    Metys J; Metysova J; Horakova Z
    Therapie; 1965; 20(3):605-15. PubMed ID: 5840875
    [No Abstract]   [Full Text] [Related]  

  • 3. [Gastrointestinal complications occurring in modern antirheumatic treatment].
    BRAUCH F
    Med Klin; 1959 Sep; 54():1629-34. PubMed ID: 13803955
    [No Abstract]   [Full Text] [Related]  

  • 4. [KETOPHENYLBUTAZONE IN THE TREATMENT OF VENOUS THROMBOSIS. A NEW PYRAZOLONE DERIVATIVE WITH HIGH GASTRIC TOLERANCE].
    CEPELAK V; HORAKOVA Z
    Z Gesamte Inn Med; 1963 Jul; 18():612-6. PubMed ID: 14047069
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatorenal lesions in the course of experimental ulcers caused by phenylbutazone in dogs; observations on the protective effects of gastrointestinal extracts].
    DASCALAKIS T; PAPACHARALAMBOUS N; CHRYSOSPATHIS P
    Arch Mal Appar Dig Mal Nutr; 1956; 45(1-2):116-25. PubMed ID: 13314779
    [No Abstract]   [Full Text] [Related]  

  • 6. [Gastroduodenal ulcers revealed or aggravated by corticoids or phenylbutazone].
    LESCUT J
    Lille Med; 1962 Mar; 7():194-7. PubMed ID: 14464278
    [No Abstract]   [Full Text] [Related]  

  • 7. SPECIES VARIATION IN PHENYLBUTAZONE INDUCED EXPERIMENTAL PEPTIC ULCERATION.
    BHATIA A; ZAIDI SH; SINGH GB
    Indian J Exp Biol; 1965 Apr; 3():144-5. PubMed ID: 14338065
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxicity studies of 4-allyloxy-3-chlorophenylacetic acid, a new analgesic, antipyretic, and anti-inflammatory agent.
    Lambelin G; Roba J; Gillet C; Gautier M; Buu-Hoï NP
    Arzneimittelforschung; 1970 May; 20(5):618-30. PubMed ID: 4987565
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental peptic ulcer.
    Brodie DA
    Gastroenterology; 1968 Jul; 55(1):125-34. PubMed ID: 4969595
    [No Abstract]   [Full Text] [Related]  

  • 10. [Peptic ulcer in relation to phenylbutazone therapy].
    GUISASOLA PEREZ T
    Rev Clin Esp; 1956 May; 61(4):247-50. PubMed ID: 13350781
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental acute phenylbutazone peptic ulceration.
    BAJPAI RP; SINGH GB; ZAIDI SH
    Indian J Med Res; 1962 May; 50():381-6. PubMed ID: 13864099
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preliminary pharmacologic trials of new phenylbutazone esters].
    Sugawara SH; Oga S; Yasaka WJ; Santoro MI
    Boll Chim Farm; 1978 Feb; 117(2):90-101. PubMed ID: 743362
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 2. Ulcerogenic effects in rats and dogs.
    Marazzi-Uberti E; Bianchi C; Gaetani M; Pozzi L
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:191-6. PubMed ID: 5067472
    [No Abstract]   [Full Text] [Related]  

  • 14. Early formation of peptic ulcer with perforation following phenylbutazone; a case report.
    ADELMAN FP; ZASLOW J
    J Albert Einstein Med Cent (Phila); 1956 Sep; 4(4):136-9. PubMed ID: 13357440
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gastric ulceration in white rats caused by administration of phenylbutazone; study of mechanism of action].
    BONFILS S; HARDOUIN JP; DELBARRE F
    C R Seances Soc Biol Fil; 1954 May; 148(9-10):881-3. PubMed ID: 13219821
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of partial hepatectomy on the ulcerogenic power of phenylbutazone in rats].
    Bucciarelli G; Biliotti G; Pirani A; Masi C; Mori V
    Arch De Vecchi Anat Patol; 1966 Aug; 47(3):823-36. PubMed ID: 5987400
    [No Abstract]   [Full Text] [Related]  

  • 17. [The ulcer-producing action of phenylbutazone].
    GOSPODINOFF A
    Policlinico Prat; 1955 May; 62(20):666-9. PubMed ID: 13245464
    [No Abstract]   [Full Text] [Related]  

  • 18. Further comments on the ulcer-producing action of phenylbutazone.
    GOSPODINOFF A
    Policlinico Prat; 1955 May; 62(22):730-2. PubMed ID: 13245469
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ketophenylbutazone. Preliminary clinical observations. Experimental study on the ulcerogenic activity].
    GOSPODINOFF A; GOSPODINOFF L; FIORE L
    Minerva Med; 1962 Jan; 53():97-101. PubMed ID: 13900640
    [No Abstract]   [Full Text] [Related]  

  • 20. [Gastro-duodenal complications resulting from the use of antirheumatic substances of the phenylbutazone group].
    DE CASTRO FP; ROIMICHER S
    Arq Bras Med; 1956; 46(3-4):103-8. PubMed ID: 13328597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.